These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3351041)

  • 1. Benefits of Gd-DTPA for MR imaging of intracranial abnormalities.
    Hesselink JR; Healy ME; Press GA; Brahme FJ
    J Comput Assist Tomogr; 1988; 12(2):266-74. PubMed ID: 3351041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramagnetic enhancement of cerebral lesions with gadolinium-DTPA.
    Hesselink JR; Dunn WM; Healy ME; Hajek P; Baker L; Brahme FJ
    Acta Radiol Suppl; 1986; 369():558-60. PubMed ID: 2980556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
    Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
    Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gd-DTPA-enhanced MR imaging in pediatric patients after brain tumor resection.
    Bird CR; Drayer BP; Medina M; Rekate HL; Flom RA; Hodak JA
    Radiology; 1988 Oct; 169(1):123-6. PubMed ID: 3420247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with routine Gd-DTPA administration for MR imaging of the brain.
    Schwaighofer BW; Klein MV; Wesbey G; Hesselink JR
    J Comput Assist Tomogr; 1990; 14(1):11-7. PubMed ID: 2298973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT.
    Chang KH; Han MH; Roh JK; Kim IO; Han MC; Kim CW
    AJNR Am J Neuroradiol; 1990; 11(1):69-76. PubMed ID: 2105619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT.
    Chang KH; Han MH; Roh JK; Kim IO; Han MC; Kim CW
    AJR Am J Roentgenol; 1990 Apr; 154(4):809-16. PubMed ID: 2107681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
    Wessbecher FW; Maravilla KR; Dalley RW
    AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracranial lesions of the head and neck: preliminary experience with Gd-DTPA-enhanced MR imaging.
    Robinson JD; Crawford SC; Teresi LM; Schiller VL; Lufkin RB; Harnsberger HR; Dietrich RB; Crim JR; Duckwiler GR; Spickler EM
    Radiology; 1989 Jul; 172(1):165-70. PubMed ID: 2740499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased detection of intracranial metastases with intravenous Gd-DTPA.
    Healy ME; Hesselink JR; Press GA; Middleton MS
    Radiology; 1987 Dec; 165(3):619-24. PubMed ID: 3317496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions.
    Brant-Zawadzki M; Berry I; Osaki L; Brasch R; Murovic J; Norman D
    AJR Am J Roentgenol; 1986 Dec; 147(6):1223-30. PubMed ID: 3490758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gd-DTPA-enhanced cranial MR imaging in children: initial clinical experience and recommendations for its use.
    Elster AD; Rieser GD
    AJR Am J Roentgenol; 1989 Dec; 153(6):1265-8. PubMed ID: 2816645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain.
    Stack JP; Antoun NM; Jenkins JP; Metcalfe R; Isherwood I
    Neuroradiology; 1988; 30(2):145-54. PubMed ID: 3386808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Gd-DTPA required for routine cranial MR imaging?
    Elster AD; Moody DM; Ball MR; Laster DW
    Radiology; 1989 Oct; 173(1):231-8. PubMed ID: 2781014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging with gadolinium contrast agent in small deep (lacunar) cerebral infarcts.
    Regli L; Regli F; Maeder P; Bogousslavsky J
    Arch Neurol; 1993 Feb; 50(2):175-80. PubMed ID: 8431136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
    Fang YX
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
    Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
    AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contrast-enhanced MR imaging using double doses of gadolinium-DTPA in evaluating brain and spinal diseases].
    Matsumoto S; Hasuo K; Uchino A; Matsuura Y; Gibo M; Fukui M; Masuda K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May; 53(5):503-10. PubMed ID: 8327315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.